Sabra Health Care REIT, Inc. (SBRA) — Financial statements
Income statement, balance sheet, and cash flow for Sabra Health Care REIT, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 775↑10.2% | 703↑8.6% | 648↑3.6% | 625↑9.7% | 570 | |
| Cost of Revenue | 271↑19.4% | 227↑16.3% | 195↑20.1% | 163↑15.2% | 141 | |
| Gross Profit | 504↑5.8% | 476↑5.3% | 452↓2.1% | 462↑7.9% | 428 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 54↑7.3% | 50↑5.5% | 47↑20.0% | 40↑14.1% | 35 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 54↑7.3% | 50↑5.5% | 47↑20.0% | 40↑14.1% | 35 | |
| Other Expenses | 186↑10.0% | 169↓7.7% | 183↓2.5% | 188↑2.7% | 183 | |
| Operating Expenses | 240↑9.4% | 219↓5.0% | 231↑1.4% | 227↑4.5% | 218 | |
| Total Costs & Expenses | 511↑14.5% | 446↑4.8% | 426↑9.2% | 390↑8.7% | 359 | |
| Operating Results | ||||||
| Operating Income | 264↑2.7% | 257↑15.9% | 222↓5.6% | 235↑11.4% | 211 | |
| Depreciation & Amortization | 187↑10.2% | 170↓7.4% | 183↓2.5% | 188↑4.9% | 179 | |
| EBITDA | 457↑10.7% | 413↑32.3% | 312↑43.8% | 217↑30.5% | 166 | |
| EBIT | 270↑11.0% | 243↑88.8% | 129↑342.2% | 29↑327.8% | -13 | |
| Interest & Other Income | ||||||
| Net Interest Income | -112↑2.4% | -115↓2.0% | -113↓7.1% | -105↓6.9% | -99 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 112↓2.4% | 115↑2.0% | 113↑7.1% | 105↑6.9% | 99 | |
| Non-Operating Income | -6↓142.5% | 14↓84.9% | 93↓54.8% | 206↓8.0% | 224 | |
| Other Income / Expenses | -107↑17.6% | -129↑37.2% | -206↑33.8% | -311↑3.4% | -322 | |
| Income Before Tax | 157↑23.2% | 128↑710.5% | 16↑120.6% | -76↑31.5% | -111 | |
| Income Tax Expense | 2↑82.8% | 1↓49.8% | 2↑61.2% | 1↓32.7% | 2 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 156↑22.7% | 127↑821.1% | 14↑117.7% | -78↑31.5% | -113 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 156↑22.8% | 127↑821.1% | 14↑117.7% | -78↑31.5% | -113 | |
| Bottom-Line Net Income | 156↑22.8% | 127↑821.1% | 14↑117.7% | -78↑31.5% | -113 | |
| EPS (Basic) | 0.64↑18.5% | 0.54↑807.6% | 0.06↑117.5% | -0.34↑34.6% | -0.52 | |
| EPS (Diluted) | 0.64↑18.5% | 0.54↑813.7% | 0.06↑117.4% | -0.34↑34.6% | -0.52 | |
| Weighted Average Shares | 241↑3.3% | 233↑1.0% | 231↑0.1% | 231↑5.4% | 219 | |
| Weighted Average Diluted Shares | 244↑3.6% | 236↑1.4% | 233↑0.8% | 231↑5.4% | 219 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.